http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2225689-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41ef34b13b05b0f6b7f08fb2479edadb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
filingDate 2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6304a3457b40f861a74f271001dce7b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2586b492faf26e4cf19a68a67d6840b
publicationDate 2010-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2225689-A2
titleOfInvention Novel disease treatment by predicting drug association
abstract The present invention relates to methods for drug repositioning. More particularly, this invention relates to methods for selecting approved drugs or combinations of approved drugs for use in new therapeutic indications. This approach is situated in a cross section between drug repositioning and disease treatment by combinations of drugs with additive or synergistic action. The invention also allows to define drugs or drug combinations for treating the unmet medical need in diseases neglected by majority of Pharma companies, such as orphan diseases.
priorityDate 2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129467351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128272043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44258291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134385933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136046180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127776308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128784833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128342817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128808200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2889

Total number of triples: 35.